• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

135
16
14
14
9

COUNTRY

14
1
1
1
1

PRICE

101
195
336
471

PUBLISHED

50
59
132
471

PRODUCT TYPE

416
41
10
4

Respiratory

Respiratory drugs and is a growing sector of the pharmaceuticals industry, and we have all the information resources that you need to be a leading player in this lucrative market. The publications listed under Research and Markets’ Respiratory category cover all drugs and therapeutics for conditions and diseases relating to the lungs and/or breathing, such as Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, COPD (chronic obstructive pulmonary disease), cystic fibrosis, emphysema, lung disease, pneumonia, sinus infections, sleep apnea and others.

Our reports, books, and subscriptions will provide you with the latest industry news, forecasts, market trends and company profiles of market leaders and niche players including: Accentia Biopharmaceuticals, Aerogen, Aerovance, airPharma, AstraZeneca, Aventis Pharma, Bespak, Boehringer Ingelheim Pharmaceuticals, Cadila Pharmaceuticals, Dr. Reddys Laboratories, EvoGenix, GlaxoSmithKlineInyx, The Merck Generics Group, Novartis AG, Pfizer, Ranbaxy Laboratories, Respironics, Sandoz International, Schering-Plough, etc.

Publications on smoking cessation are listed under the OTC sub-category in the Pharmaceuticals section. Show Less
Read more

PRODUCT TITLE

Quilizumab (Asthma) - Forecast and Market Analysis to 2023

Quilizumab (Asthma) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Quilizumab (Asthma) - Forecast and Market Analysis to 2023”....

August 2014
FROM

Flovent (Asthma) - Forecast and Market Analysis to 2023

Flovent (Asthma) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Flovent (Asthma) - Forecast and Market Analysis to 2023”. The...

August 2014
FROM

Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023

Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Bosatria (Mepolizumab) (Asthma) - Forecast and...

August 2014
FROM

Singulair (Asthma) - Forecast and Market Analysis to 2023

Singulair (Asthma) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Singulair (Asthma) - Forecast and Market Analysis to 2023”....

August 2014
FROM

Breo Ellipta (Asthma) - Forecast and Market Analysis to 2023

Breo Ellipta (Asthma) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Breo Ellipta (Asthma) - Forecast and Market Analysis to...

August 2014
FROM

Benralizumab (Asthma) - Forecast and Market Analysis to 2023

Benralizumab (Asthma) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Benralizumab (Asthma) - Forecast and Market Analysis to...

August 2014
FROM

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented...

August 2014
FROM

PharmaPoint: Asthma - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - US Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented...

August 2014
FROM

Dupilumab (Asthma) - Forecast and Market Analysis to 2023

Dupilumab (Asthma) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Dupilumab (Asthma) - Forecast and Market Analysis to 2023”....

August 2014
FROM

Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014

Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014" provides...

August 2014
FROM

Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014

Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014" provides...

August 2014
FROM

Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014

Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014" provides...

August 2014
FROM

Bronchiectasis - Pipeline Review, H2 2014

Bronchiectasis - Pipeline Review, H2 2014 Summary This, ‘Bronchiectasis - Pipeline Review, H2 2014’, provides an overview of the Bronchiectasis’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM

Perennial Allergic Rhinitis - Pipeline Review, H2 2014

Perennial Allergic Rhinitis - Pipeline Review, H2 2014 Summary This, ‘Perennial Allergic Rhinitis - Pipeline Review, H2 2014’, provides an overview of the Perennial Allergic Rhinitis’s therapeutic...

August 2014
FROM

Lymphangioleiomyomatosis - Pipeline Review, H2 2014

Lymphangioleiomyomatosis - Pipeline Review, H2 2014 Summary This, ‘Lymphangioleiomyomatosis - Pipeline Review, H2 2014’, provides an overview of the Lymphangioleiomyomatosis’s therapeutic pipeline. This...

July 2014
FROM

Chronic Bronchitis - Pipeline Review, H2 2014

Chronic Bronchitis - Pipeline Review, H2 2014 Summary This, ‘Chronic Bronchitis - Pipeline Review, H2 2014’, provides an overview of the Chronic Bronchitis’s therapeutic pipeline. This report provides...

July 2014
FROM

Allergic Rhinitis - Pipeline Review, H2 2014

Allergic Rhinitis - Pipeline Review, H2 2014 Summary This, ‘Allergic Rhinitis - Pipeline Review, H2 2014’, provides an overview of the Allergic Rhinitis’s therapeutic pipeline. This report provides...

July 2014
FROM

Respiratory Depression - Pipeline Review, H2 2014

Respiratory Depression - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Respiratory Depression - Pipeline Review, H2 2014’, provides an overview of the Respiratory Depression’s therapeutic...

July 2014
FROM

OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update

OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion...

July 2014
FROM

Allergic Asthma - Pipeline Review, H1 2014

Allergic Asthma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Allergic Asthma - Pipeline Review, H1 2014’, provides an overview of the Allergic Asthma’s therapeutic pipeline. This...

June 2014
FROM
Loading Indicator

Our Clients

Our clients' logos